Outpatient diuretic intensification: a simple prognostic marker in cardiac transthyretin amyloidosis
ODI occurred in one in four ATTR-CM patients within 6 months and was associated with more severe baseline amyloid organ manifestations. ODI and the magnitude of diuretic dose increase provide easily assessable clinical markers of disease progression in patient monitoring.
Authors
- Stephan Nienaber (ORCID: https://orcid.org/0000-0001-5779-7549)
- Roman Pfister (ORCID: https://orcid.org/0000-0002-4358-5008)
- Matthieu Schäfer (ORCID: https://orcid.org/0000-0003-1875-1163)
- Sascha Macherey‐Meyer (ORCID: https://orcid.org/0000-0002-7080-6611)
- Jasper F. Nies (ORCID: https://orcid.org/0000-0003-3751-4008)
- Richard J. Nies (ORCID: https://orcid.org/0000-0002-1336-6031)
- Monique Brüwer (ORCID: https://orcid.org/0000-0002-0152-3407)
- Katharina Seuthe
- Svenja Ney
- Lukas Klösges
Institutions
- University of Cologne (DE)
- University Hospital Cologne (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1007/s00392-025-02617-4
- Citations
- 2
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- Universitätsklinikum Köln